We are pleased to announce that we have entered into a strategic partnership with Gilead Sciences to conduct analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products.  WuXi’s Lab Testing Division (LTD) will equip and operate a dedicated, fully cGMP-compliant analytical testing facility in Shanghai with dedicated staff.   The opening of this analytical and stability testing center is an important milestone in the ongoing long-term relationship between Gilead and WuXi.  We are determined to enable our innovative partners like Gilead through our open-access R&D platform, and we are honored to help advance some of the most innovative medicines faster to patients.

 

Related Links:

  1. WuXi to Be Exclusive Supplier of Laboratory Testing Services to Lee’s Pharm
  2. WuXi Launches Medical Device Testing Services in China